Rhabdomyosarcomas Flashcards
Most Common Sites for Rhabdo (Descending order) “ONES”
Orbit (25%)
Nasopharynx
Ear (middle)/mastoid
Sinonasal cavity
Most Common Sites for Rhabdo (Descending order) “ONES”
Orbit (25%)
Nasopharynx
Ear (middle)/mastoid
Sinonasal cavity
Most common metastatic sites for rhabdomosarcoma? (3)`
Lungs
Bone
Bone Marrow
Classification of Rhabdo according to site (3)
Which ones of the three are favourable vs. unfavourable?
- Orbital (MC)
- Parameningeal (NP, middle ear, sinuses, infratemporal fossa/pterygopalatine) - worse prognosis due to skullbase nearby so harder surgery
- Non-parameningeal - easier access so amenable to surgery
Superficial sites = Scalp, cheek, external ear
Deep sites = larynx, parotid, oral cavity, oropharynx
Orbital + Non-Parameningeal = favourable
Non-parameningeal = unfavourable
Histological Classification of Rhabdomyosarcoma (4)
- Embryonal (Classic) - Chr 11, IGF-2 gene
- Embryonal (Botyroid)
- Embryonal (Spindle Cell)
- Alveolar - poor prognosis
- Pleomorphic/Anaplastic
- Undifferentiated
Most common metastatic sites for rhabdomosarcoma? (3)`
Lungs
Bone
Bone Marrow
Classification of Rhabdo according to site (3)
Which ones of the three are favourable vs. unfavourable?
- Orbital (MC)
- Parameningeal (NP, middle ear, sinuses, infratemporal fossa/pterygopalatine) - worse prognosis due to skullbase nearby so harder surgery
- Non-parameningeal - easier access so amenable to surgery
Superficial sites = Scalp, cheek, external ear
Deep sites = larynx, parotid, oral cavity, oropharynx
Orbital + Non-Parameningeal = favourable
Non-parameningeal = unfavourable
Histological Classification of Rhabdomyosarcoma (4)
- Embryonal (Classic) - Chr 11, IGF-2 gene
- Embryonal (Botyroid)
- Embryonal (Spindle Cell)
- Alveolar - poor prognosis
- Pleomorphic/Anaplastic
- Undifferentiated
Immunohistochemical Stains for Rhabdomyosarcoma (3)
Myogenin
Muscle Specific Actin
Desmin
TNMStaging of Rhabdomyosarcoma
T staging o T1 – Confined to anatomic site of origin o T2 – Extension and/or fixation to surrounding tissue o A ≤5cm in diameter o B >5cm in diameter N staging o N0 – Not clinically involved o N1 – Clinically involved o Nx – Clinical status unknown M staging o M0 – No distant metastases M1 – Distant metastasis
o I – Head and Neck (Orbit, non-PM); T1 or T2, A or B; any N; M0
o II – Parameningeal; T1 or T2, A; N0 or Nx; M0
o III – Parameningeal; T1 or T2, B; any N; M0
IV – All sites; T1 or T2, A or B; any N; M1
Treatment of Rhabdomyosarcoma
- Induction Chemo for all cases first
- Surgery - only if 2cm margin and not recommended if cause cosmetic deformity or no increase in survival compared to ChemoRT (use in salvage therapy)
- Radiation (40-50Gy) for post op in gross or microscopic disease
- Do not treat neck unless Stage 2 (ie. N+)